Australia TGA ARTG recordDermatological excimer laser system
Australia TGA ARTG Registered Device · Allied Biotech Australia Pty Ltd · Clarteis SAS · Class IIb · Started September 29, 2022
Good Name: Allied Biotech Australia Pty Ltd - Dermatological excimer laser system
- Risk Class
- Class IIb
- Product Type
- Single Device Product
- ARTG Category
- General
- Start Date
- September 29, 2022
- Effective Date
- September 29, 2022
- Name
- Clarteis SAS
- Country
- France
- Address
- WTC2 120 route des macarons, Valbonne, Sophia Antipolis, 06 560
Excimer light, used for the treatment of dermatological conditions including vitiligo, Alopecia Areata, Mycosis Fungoides, Atopic Dermatitis, psoriasis and eczema.
Access comprehensive regulatory information for Dermatological excimer laser system in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIb is sponsored by Allied Biotech Australia Pty Ltd, manufactured by Clarteis SAS in France. The device registration started on September 29, 2022.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.